Global Plant Gene Expression Microarrays Industry: High-Throughput Transcriptomics for Crop Improvement – Strategic Outlook 2026-2032

Global Leading Market Research Publisher QYResearch announces the release of its latest report “Plant Gene Expression Microarrays – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032″. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Plant Gene Expression Microarrays market, including market size, share, demand, industry development status, and forecasts for the next few years.

The global market for Plant Gene Expression Microarrays was estimated to be worth US16.2millionin2025andisprojectedtoreachUS16.2millionin2025andisprojectedtoreachUS21.1 million by 2032, growing at a CAGR of 3.9% from 2026 to 2032. For plant molecular biologists, agricultural biotech researchers, and crop breeding scientists, the core business imperative lies in utilizing plant gene expression microarrays that address the critical need for high-throughput, simultaneous quantification of thousands of gene transcripts (mRNA) in plant cells or tissues—enabling comparative analysis of gene expression under different conditions (biotic stress (pathogen, pest), abiotic stress (drought, salinity, heat, cold), hormone treatment, development stages, tissue-specific expression, mutant vs wild-type, genetically modified (GM) crop characterization). Plant gene expression microarrays are based on DNA microarray technology where specific oligonucleotide probes (50-80mer) complementary to target gene sequences are immobilized on solid surface (glass slide, silicon chip). Fluorescently labeled cDNA (complementary DNA) or cRNA from sample hybridizes to probes; fluorescence intensity quantifies transcript abundance. Types: in situ synthesis (Agilent, NimbleGen, Affymetrix—photolithography or inkjet printing) and pre-synthesis followed by spotting (spotted arrays). Applications: breeding (marker-assisted selection, gene expression QTL (quantitative trait locus), stress tolerance screening, yield improvement, quality traits), scientific research (functional genomics, transcriptomics, gene regulatory networks, developmental biology, circadian rhythms, phytohormone signaling), and other (GM crop safety assessment, phytopathology, forestry, horticulture). Key model species (Arabidopsis thaliana, rice (Oryza sativa), maize (Zea mays), soybean (Glycine max), wheat (Triticum aestivum), tomato (Solanum lycopersicum), poplar (Populus trichocarpa), Brachypodium distachyon). Platforms: Thermo Fisher (Affymetrix GeneChip), Agilent, Illumina (BeadChip), Lasso Biochip Technology (China), Wuhan Shuanglvyuan.

【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/releases/6093268/plant-gene-expression-microarrays

The Plant Gene Expression Microarrays market is segmented as below:
Thermo Fisher Scientific
Agilent
Illumina
Lasso Biochip Technology
Wuhan Shuanglvyuan Chuangxin Technology Research Institute

Segment by Type
In Situ Synthesis
Pre-synthesis Followed by Spotting

Segment by Application
Breeding
Scientific Research
Other

1. Market Drivers: RNA-seq Competition, Cost-Effectiveness, and Established Databases

Several powerful forces are driving the plant gene expression microarray market:

RNA-seq displacement (low-cost vs high-throughput) – RNA-seq (RNA sequencing) offers higher dynamic range, novel transcript discovery, but higher cost per sample (US100−300)vsmicroarray(US100−300)vsmicroarray(US50-100). Microarray remains cost-effective for large sample sets (>1000). Platform comparison.

Large public databases (ArrayExpress, GEO, PlantGEO) – Decades of microarray data (Arabidopsis, rice, maize). Re-analysis, meta-analysis. Data reuse.

Crop breeding and GM regulatory studies – Comparative gene expression profiling (GM vs non-GM) for regulatory approval (USDA (United States Department of Agriculture), EFSA (European Food Safety Authority)). Transcriptional equivalence.

Recent market data (December 2025): According to Global Info Research analysis, in situ synthesis microarrays (Agilent, Affymetrix) dominate with approximately 70% revenue share (higher probe density, consistency, commercial). Pre-synthesis spotting 30% share (custom arrays, lower cost). Scientific research (academic) largest application (70% share). Breeding (agricultural biotech, seed companies) 25% share (fastest-growing). Others (GM regulation, forestry) 5% share. North America (US) largest market (45% share). Europe (Germany, UK) 25% share. Asia-Pacific (China, Japan) 20% share. Thermo Fisher (Affymetrix) leader (plant GeneChip varieties). Agilent (custom arrays). Illumina (BeadChips discontinued? (BeadArray still). Lasso, Wuhan Shuanglvyuan China domestic.

2. Microarray Types and Specifications

Type Fabrication Probe Density (per slide) Species Coverage Customization Cost Share
In Situ Synthesis Photolithography (Affy) or inkjet (Agilent) >100,000-1,000,000 Model species (Arabidopsis, rice, maize) Limited (fixed catalog) High ~70%
Pre-synthesis Spotting Robot pin spotting 5,000-50,000 Any species (custom) High (customer probes) Low ~30%

Key specifications: Whole genome coverage (30,000+ genes). Probe length (25-80mer). Single vs dual color labeling (Cy3, Cy5). Detection (fluorescent scanner). Dynamic range (2-3 logs). Limit of detection (1-10 copies per cell). Sample requirement (10-100 ng total RNA). Data analysis software (Agilent GeneSpring, Affymetrix Transcriptome Analysis Console (TAC), R/Bioconductor (limma)). Validated for Arabidopsis, rice, maize, soybean, tomato, wheat, barley, sorghum, poplar, Brachypodium.

Exclusive observation (Global Info Research analysis): Plant gene expression microarray market is mature, declining (RNA-seq competition), but stable (established databases, large longitudinal studies). Thermo Fisher (Affymetrix) main provider (Arabidopsis ATH1, Rice Genome Array, Maize Genome Array). Agilent custom arrays (Any species). Illumina discontinued BeadChips for plants? Lasso Biochip (China) and Wuhan Shuanglvyuan domestic.

User case – abiotic stress response (December 2025): Plant research lab (Europe) uses Affymetrix Arabidopsis ATH1 microarray (22,000 genes) to study drought stress response (root tissue, control vs PEG (polyethylene glycol) treatment). Three biological replicates. Differentially expressed genes (DEGs) (MAPK, ABA (abscisic acid), transcription factors). Validation qPCR.

User case – rice hybrid breeding (January 2026): Seed company (China) uses custom spotted array (Lasso Biochip) to compare gene expression between hybrid rice (two-line) and parents (heterosis). 50,000 probes. Identify differentially expressed genes (yield-related). Molecular marker development.

3. Technical Challenges

Probe design and cross-hybridization – Paralogous genes (gene families) cross-hybridize (false positives). Specific probe design.

Limited to known transcripts (no novel discovery) – Pre-defined probe sets. RNA-seq required for novel transcripts.

Technical difficulty – array normalization: Between-array normalization (quantile, RMA (Robust Multi-array Average), GC-RMA (Guanine-Cytosine Robust Multi-array Average)). Batch effects.

Technical development (October 2025): Agilent introduced SurePrint G3 Plant Custom Microarray (inkjet) for any species (submit custom probe sequences). 180,000 probes per slide.

4. Competitive Landscape

Key players include: Thermo Fisher Scientific (US – Affymetrix GeneChip), Agilent (US – custom arrays), Illumina (US – BeadChip, limited), Lasso Biochip Technology (China), Wuhan Shuanglvyuan Chuangxin Technology Research Institute (China). Thermo Fisher, Agilent leaders.

Regional dynamics: North America (Thermo Fisher, Agilent) largest market. Europe (Agilent). China (Lasso, Shuanglvyuan) domestic.

5. Outlook

Plant gene expression microarray market will grow at 3.9% CAGR to US$21.1 million by 2032, driven by cost-effectiveness for large sample sets, established databases (data reuse), and breeding applications. RNA-seq continues to displace in functional genomics, but microarrays remain for regulatory studies (GM). Technology trends: custom arrays (any species), hybrid microarray-RNA-seq workflow (discovery followed by screening). Asia-Pacific growth (5-6% CAGR).


Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:

QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp


カテゴリー: 未分類 | 投稿者huangsisi 15:53 | コメントをどうぞ

コメントを残す

メールアドレスが公開されることはありません。 * が付いている欄は必須項目です


*

次のHTML タグと属性が使えます: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong> <img localsrc="" alt="">